PXE International Research

PXE research has moved from gene discovery to treatment development, clinical trial readiness and clinical trials, and the search for reliable ways to measure whether a treatment is working.

PXE is caused by changes in the ABCC6 gene. These changes reduce circulating inorganic pyrophosphate, or PPi, a natural substance in the blood that helps prevent unwanted mineralization. Much current PXE research focuses on understanding this mineralization process, measuring disease progression, and developing treatments that may slow, stop, or prevent damage to the skin, eyes, arteries, and other affected tissues.

PXE International supports and conducts research to better understand:

• what PXE looks like across a lifetime
• how PXE progresses
• why people with PXE are affected differently
• which symptoms matter most to people living with PXE
• which biomarkers and clinical measures are useful for trials
• how potential treatments should be tested

PXE International’s research portal is the central place for people affected by PXE to participate in research. By registering or logging in, participants can share their experience, update their information, learn about research opportunities, and help build the evidence needed for future clinical trials.

PXE International has supported basic research, animal model development, natural history studies, biomarker work, clinical studies, and clinical trials. Models of PXE, including mouse, rat, and zebrafish models, help researchers study disease mechanisms and potential treatments before they are tested in people.

Eye research remains especially important. Current work includes studies of retinal changes, angioid streaks, choroidal neovascularization, dark adaptation, Bruch’s membrane calcification, and treatments that may preserve vision. Anti-VEGF injections have changed the outlook for many people with PXE-related retinal bleeding, but they do not treat the underlying cause of PXE. Research is now moving toward earlier measurement, better monitoring, and treatments that may address the mineralization process itself.

What Are Clinical Trials?

Clinical trials are structured research studies designed to answer specific medical questions. They may test a new drug, device, procedure, behavioral approach, or way of monitoring a disease. Some trials compare one treatment with another. Others test whether a treatment is safe, whether it changes a biomarker, or whether it improves symptoms or function.

Clinical trials are the way researchers determine whether something works, how well it works, for whom it works, and what risks it may carry.

Before a treatment is tested in people, researchers usually study it in cells, animal models, or earlier human studies to understand safety and biological plausibility. Even if a drug is already used for another disease, it still needs to be studied carefully in PXE because PXE has its own biology, risks, and treatment goals.

Clinical trials are reviewed by ethics committees or institutional review boards. These groups evaluate whether the study is scientifically justified, whether risks are reasonable, and whether participants are given clear information before deciding whether to join.

Participation in a clinical trial is voluntary. People who join studies make research possible, but they should never be pressured to participate. A well-designed trial respects participants, protects safety, and asks a clear scientific question.

Informed Consent

Informed consent is the process of learning about a study before deciding whether to participate. It is not just a form. It should be an ongoing conversation between the study team and the participant.

Before joining a study, participants should be told:

• why the study is being done
• what they will be asked to do
• what information or samples will be collected
• what risks and discomforts are possible
• whether there may be direct benefit
• what alternatives are available
• how privacy and data will be protected
• whether results will be returned
• whether participation can be stopped later

Participants have the right to ask questions, take time to decide, and withdraw from a study according to the consent terms. Good research depends on trust, clarity, and respect for the people who make the research possible.

Why Participation Matters

PXE is rare. No single clinic or researcher can understand PXE without the participation of people living with the condition.

When people with PXE register, answer surveys, contribute medical information, provide samples, or join studies, they help researchers understand the natural history of PXE and design better clinical trials. Without participation from people affected by PXE, researchers cannot reliably measure progression, choose meaningful endpoints, or test potential treatments efficiently.

Every person’s experience adds to the evidence needed to move PXE research forward. Join today.

You are an important piece of the puzzle!